Related Experiment Video
Updated: Jul 13, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
The IKK inhibitor BMS-345541 affects multiple mitotic cell cycle transitions
Hana Blazkova1, Conrad von Schubert, Keith Mikule
1Division of Molecular Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
The IkappaB kinase (IKK) inhibitor BMS-345541 disrupts mitosis, affecting cell cycle progression and cytokinesis. This reveals a novel role for IKK in regulating cell division, potentially impacting cancer therapeutics.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The IkappaB kinase (IKK) complex regulates inflammation, immune responses, and cell proliferation.
- IKK activation of NFkappaB is known to promote G1/S transition, and IKKalpha has been implicated in mitotic entry.
- The precise role of IKK in mitotic progression and cytokinesis remains undetermined.
Purpose of the Study:
- To investigate the role of IKK in mitosis and cytokinesis using the specific inhibitor BMS-345541.
- To determine how IKK inhibition affects key mitotic events and cell cycle transitions.
Main Methods:
- Utilized BMS-345541, a potent allosteric inhibitor of IKK, to specifically target IKK during G2 and mitosis.
- Observed effects on mitotic entry, prometaphase-anaphase progression, and cytokinesis.
- Performed in vitro kinase assays to assess direct effects on mitotic kinases.
Main Results:
- BMS-345541 treatment inhibited mitotic entry, Cdk1 activation, histone H3 phosphorylation, and Aurora kinase activity.
- IKK inhibition led to premature degradation of cyclin B1 and securin, causing defective chromosome separation and cytokinesis.
- BMS-345541 overrode the spindle checkpoint in nocodazole-treated cells.
- In vitro assays suggested effects were not due to direct inhibition of major mitotic kinases.
Conclusions:
- IKK plays a significant role in regulating multiple stages of mitosis, including entry, progression, and cytokinesis.
- BMS-345541's impact on cell cycle progression highlights a novel function of IKK.
- These findings offer potential therapeutic strategies targeting cell cycle control in cancer.
More Related Videos
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules
Positive Regulator Molecules